| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 28 |
| 1 | PREDNISONE | 24 |
| 2 | CYCLOPHOSPHAMIDE | 23 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 23 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 23 |
| 5 | METHYLPREDNISOLONE | 19 |
| 6 | PREDNISOLONE | 18 |
| 7 | PREDNISOLONE ORAL | 18 |
| 8 | PREDNISOLONE ORAL SOLUTION | 18 |
| 9 | TACROLIMUS | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 1 | IBRITUMOMAB TIUXETAN | 2 | 0.0013 |
| 2 | ZONISAMIDE | 10 | 0.0009 |
| 3 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 4 | OXCARBAZEPINE | 10 | 0.0006 |
| 5 | ELETRIPTAN HYDROBROMIDE | 4 | 0.0006 |
| 6 | NORETHINDRONE | 3 | 0.0005 |
| 7 | TOFACITINIB CITRATE | 7 | 0.0005 |
| 8 | SALICYLIC ACID 12% | 1 | 0.0005 |
| 9 | ASTRINGENT | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 1 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 2 | Human Immunoglobulin G [EPC] | 8 | 0.0004 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |